Article Text
Featured correspondence
Thiazolidinediones and cardiovascular outcomes in type 2 diabetes
Statistics from Altmetric.com
Footnotes
Competing interests: Declared. The author has received honoraria from GSK, Takeda and Lilly pharmaceuticals for speaker engagements and attendance at advisory board meetings.
Linked Articles
- Featured correspondence